ResearcherTaichung Veterans General HospitalActive in the last 2 years
Kuan-Yu Tseng
Matched on ORCID iD 0009-0004-4396-6056. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 2
2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 3
- Gemcitabine/nab-paclitaxel plus S-1 combination compared with gemcitabine/nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: a retrospective study. Co-author DOI 10.1177/17588359261420081↗
- The clinical outcomes of adjuvant gemcitabine plus S-1 in resected pancreatic cancer: a single-center retrospective study. Co-author DOI 10.1186/s12885-025-14617-8↗
- The concomitant use of the renin-angiotensin system inhibitors and survival outcomes of patients with pancreatic adenocarcinoma: an analysis from a tertiary ce… Co-author DOI 10.1177/17588359241247019↗
Closest collaborators
The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hsin‐Chen Lin · 3 shared papers, 2024–2026 · strength 0.96
- Paper Gemcitabine/nab-paclitaxel plus S-1 combination compared with gemcitabine/nab-paclitaxel in advanced pancreatic ductal … DOI 10.1177/17588359261420081↗
- Paper The clinical outcomes of adjuvant gemcitabine plus S-1 in resected pancreatic cancer: a single-center retrospective stu… DOI 10.1186/s12885-025-14617-8↗
- Paper The concomitant use of the renin-angiotensin system inhibitors and survival outcomes of patients with pancreatic adenoc… DOI 10.1177/17588359241247019↗
- Cheng‐Wei Chou · 1 shared paper, 2024 · strength 0.24
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.